Profitability Ratios
| Ratio |
Value |
| GP Margin |
65.8% |
| EBIT Margin |
17.5% |
| EBITDA Margin |
28.5% |
| Operating Margin |
25.9% |
| Pretax Margin |
12.6% |
| Cont. Ops Margin |
12.7% |
| Net Margin |
12.6% |
| Bottom Line Margin |
12.6% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.17 |
| Quick Ratio |
0.92 |
| Solvency Ratio |
0.120 |
| Cash Ratio |
0.02 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
18.74 |
| PEG Ratio |
0.07 |
| Forward PEG |
0.07 |
| Price/Book |
1.70 |
| Price/Sales |
2.36 |
| Price/FCF |
15.28 |
| Price/Op Cash Flow |
11.79 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.3139 |
| Debt/Equity |
0.7595 |
| Debt/Capital |
0.4317 |
| Long-Term Debt/Capital |
0.3942 |
| Financial Leverage |
2.42 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
43.85 |
| Operating Cash Flow Ratio |
0.296 |
| Operating Cash Flow/Sales |
20.0% |
| Free Cash Flow/Operating Cash Flow |
77.2% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
1.81 |
| Interest Coverage |
5.3326 |
| Short-Term Operating Cash Flow Coverage |
1.83 |
| Operating Cash Flow Coverage |
0.19 |
| Capital Expenditure Coverage |
4.38 |
| Dividend + Capital Expenditure Coverage |
1.03 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
118.6035% |
| Dividend Yield |
6.3301% |
| Dividend Yield % |
6.3301% |
| Dividend Per Share |
1.6794 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
11.23 |
| EPS |
1.416 |
| Debt/Share |
12.3736 |
| Cash/Share |
3.62 |
| Book Value/Share |
15.62 |
| Tangible BV/Share |
-6.26 |
| Equity/Share |
15.57 |
| Operating Cash Flow/Share |
2.250 |
| Capital Expenditure/Share |
0.514 |
| FCF/Share |
1.736 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.000 |
| Earnings Before Tax/EBIT |
0.487 |
| Price/Fair Value |
1.70 |
| Debt/Market Cap |
0.4282 |
| Effective Tax Rate |
-0.3% |
| Enterprise Value Multiple |
11.93 |
PFE - Pfizer Inc.